This site is intended for healthcare professionals.

COVID-19: use of ACE inhibitors and angiotensin-receptor blockers

COVID-19: use of ACE inhibitors and angiotensin-receptor blockers

Share
Share on facebook
Share on twitter
Share on linkedin
Share on email
25 March 2020
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
David Millar-Jones examines recent newspaper stories on the use of ACE inhibitors and angiotensin-receptor blockers in people with COVID-19, and their implications for primary care

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.

We also uses anonymous cookies to generate usage statistics. Please click here to find out more.